Amole Ojo, MD
Cardiovascular Disease · Rochester, NYNPI 1982983672
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 39.0% of the total. Reporting peaked in 2019 at $7,447 and has fallen 82.1% since, to $1,333 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $194.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$5K
- Abbott$5K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$500
- Medical Device Business Services, Inc.$337
- plus $414 from 3 others
What the payments were for
- Speaking & faculty fees$2,47511%
- Grants$9014%
- Travel & lodging$12,68358%
- Food & beverage$5,13324%
- Education$5893%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 49 | $8,488 |
| Boston Scientific | 24 | $5,145 |
| Abbott | 24 | $4,645 |
| Biotronik Inc. | 3 | $2,251 |
| Biosense Webster, Inc. | 6 | $500 |
| Medical Device Business Services, Inc. | 3 | $337 |
| Impulse Dynamics (USA) Inc. | 1 | $176 |
| Abiomed | 1 | $131 |
| Kestra Medical Technology Services, Inc. | 1 | $108 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$3,387
- AVEIR$2,686
- AGILIS$1,500
- GENERAL TACHY$901
- RHYTHMIA$428
- Micra$396
- OPTIMIZER$351
- ENSITE PRECISION$190
- ADVISA DR MRI SURESCAN$185
- QDOT MICRO Catheter$141
- Impella$131
- Adapta$129
- Assure WCD$108
How this compares
$21,781 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $13,527 |
| Amiodarone Hcl | 49 | $1,179 |
| Flecainide Acetate | 22 | $1,088 |
| Metoprolol Succinate | 30 | $858 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Rochester
- James EichelbergerRochester$332K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.